A number of studies have reported that CENPF expression is overexpressed in several human malignancies including breast cancer [3], hepatocellular carcinoma [4], nasopharyngeal cancer [5], gastrointestinal stromal tumors [6], esophageal squamous cell carcinoma [7], and non-Hodgkin’s lymphoma [8]. Here, CENPF is linked to breast cancer.